Plain-English translation of NCT05737953 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Neoplasms research guide →Researchers are working to develop better diagnostic tests for pancreatic cysts by analyzing fluid samples collected during surgery. The study looks at molecular markers — essentially tiny chemical signatures — in the fluid to help doctors more accurately identify what type of cyst a patient has and how serious it might be. This research could eventually help doctors make better treatment decisions for pancreatic cyst patients.
Currently, it can be difficult for doctors to determine which pancreatic cysts are harmless and which ones might become cancer. This study aims to find new molecular markers that would allow for faster, more accurate diagnosis without relying solely on imaging scans.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo surgery to remove your pancreatic cyst as planned. During that surgery, doctors will collect a sample of fluid from the cyst. Researchers will then analyze this fluid sample using special laboratory techniques to study its molecular markers. Your participation essentially involves allowing researchers to study the cyst fluid that would otherwise be discarded during your surgery — no additional procedures or visits beyond your standard surgical care.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China